Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
118.9 USD | +2.58% | +21.98% | +57.39% |
May. 01 | UBS Adjusts Tenet Healthcare Price Target to $150 From $137, Maintains Buy Rating | MT |
May. 01 | RBC Raises Tenet Healthcare Price Target to $136 From $109, Maintains Outperform Rating | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company is in debt and has limited leeway for investment
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+57.39% | 11.62B | C+ | ||
+14.10% | 81.68B | C+ | ||
-30.15% | 69.23B | B- | ||
+9.37% | 29.08B | C+ | ||
-11.90% | 16.88B | B | ||
+0.18% | 16.85B | A- | ||
-1.12% | 15.15B | A- | ||
+5.72% | 12.62B | A- | ||
+35.78% | 12.47B | B- | ||
-3.42% | 11.66B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- THC Stock
- Ratings Tenet Healthcare Corporation